Lung Cancer Chemoprevention
Data up to Jan 2025
Total Citations Per Year
Abstract
References (116)
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 • 6,324 citations
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 • 4,048 citations
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
1996 • 3,608 citations
“Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin
1953 • 3,421 citations
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 • 3,176 citations
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 • 2,837 citations
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 • 2,774 citations
A matrix metalloproteinase expressed on the surface of invasive tumour cells
1994 • 2,561 citations
Nicotine replacement therapy for smoking cessation
2012 • 2,516 citations
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 • 2,476 citations
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
1996 • 2,429 citations
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
1989 • 2,180 citations
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 • 2,039 citations
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
1991 • 1,950 citations
Smoking and Carcinoma of the Lung
1950 • 1,909 citations
Physician advice for smoking cessation
2013 • 1,851 citations
Efficacy of Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2006 • 1,630 citations
Cigarette Smoking Among Adults--United States, 2003
2005 • 1,531 citations
Tumor Cell Interactions with the Extracellular Matrix During Invasion and Metastasis
1993 • 1,523 citations
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies
2000 • 1,391 citations
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2006 • 1,343 citations
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
2000 • 1,310 citations
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
1997 • 1,273 citations
Randomised trial of prophylactic daily aspirin in British male doctors
1988 • 1,178 citations
Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer
2005 • 1,160 citations
Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
2005 • 1,106 citations
Smoking cessation guidelines for health professionals: an update
2000 • 1,019 citations
TOBACCO SMOKING AS A POSSIBLE ETIOLOGIC FACTOR IN BRONCHIOGENIC CARCINOMA
1950 • 990 citations
The Mortality of Doctors in Relation to Their Smoking Habits
1954 • 915 citations
Interleukin-12 and its role in the generation of TH1 cells
1993 • 869 citations
Recent Advances in Chemoprevention of Cancer
1997 • 837 citations
Smoking and Lung Cancer: Recent Evidence and a Discussion of Some Questions
1959 • 816 citations
Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.
1994 • 796 citations
Cigarette Smoking Among Adults, United States
2006 • 774 citations
Low-Dose Aspirin in the Primary Prevention of Cancer
2005 • 764 citations
The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.
1993 • 756 citations
Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
1999 • 699 citations
Uninterrupted MCM2-7 Function Required for DNA Replication Fork Progression
2000 • 616 citations
Annual Report to the Nation on the Status of Cancer, 1973-1996, With a Special Section on Lung Cancer and Tobacco Smoking
1999 • 597 citations
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
2000 • 511 citations
Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.
1998 • 498 citations
Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis
2000 • 474 citations
β-Carotene Supplementation and Incidence of Cancer and Cardiovascular Disease: the Women's Health Study
1999 • 474 citations
Epidemiology of Lung Cancer: Looking to the Future
2005 • 473 citations
Targeting cyclooxygenase-2 in human neoplasia
2003 • 447 citations
Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.
1996 • 426 citations
Development of carcinoma of the lung as reflected in exfoliated cells
1974 • 422 citations
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
2001 • 410 citations
EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer
2000 • 385 citations
Second Lung Cancers in Patients After Treatment for an Initial Lung Cancer
1998 • 378 citations
The Ki-67 Protein: Fascinating Forms and an Unknown Function
2000 • 372 citations
Initiating DNA synthesis: from recruiting to activating the MCM complex
2001 • 364 citations
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
2005 • 352 citations
US public health service clinical practice guideline: treating tobacco use and dependence.
2000 • 348 citations
Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma
1999 • 333 citations
CANCER AND TOBACCO SMOKING
1950 • 322 citations
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
2001 • 318 citations
Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion
2002 • 261 citations
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.
1998 • 259 citations
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling.
1996 • 252 citations
Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44
2001 • 240 citations
Pharmacotherapy for Nicotine Dependence
2005 • 235 citations
Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.
1994 • 220 citations
Cyclooxygenase‐2 and 5‐lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy
2003 • 220 citations
Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.
2002 • 217 citations
Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents
1998 • 200 citations
IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
1995 • 194 citations
Selenium and Lung Cancer: A Quantitative Analysis of Heterogeneity in the Current Epidemiological Literature
2004 • 179 citations
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review
2001 • 168 citations
The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
1997 • 161 citations
Multiple Clonal Abnormalities in the Bronchial Epithelium of Patients With Lung Cancer
1999 • 154 citations
Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial
1988 • 154 citations
The Natural Course of Preneoplastic Lesions in Bronchial Epithelium
2005 • 153 citations
A Randomized Phase IIb Trial of Anethole Dithiolethione in Smokers with Bronchial Dysplasia
2002 • 146 citations
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.
2003 • 140 citations
The role of MCM proteins in the cell cycle control of genome duplication
1996 • 139 citations
A prospective cohort study on selenium status and the risk of lung cancer.
1993 • 139 citations
COX‐2‐dependent stabilization of survivin in non‐small cell lung cancer
2003 • 135 citations
Acupuncture for smoking cessation
2002 • 131 citations
A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium
2004 • 124 citations
Improvement in Bronchial Squamous Metaplasia in Smokers Treated With Folate and Vitamin B12
1988 • 121 citations
Cyclooxygenase 2-Dependent Expression of Survivin Is Critical for Apoptosis Resistance in Non-Small Cell Lung Cancer
2004 • 121 citations
Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase
2004 • 114 citations
N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.
2000 • 113 citations
The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finland
2009 • 107 citations
Expression of cyclooxygenase‐1 and cyclooxygenase‐2 in bronchial epithelium and nonsmall cell lung carcinoma
2002 • 95 citations
Analogs of Staurosporine
1998 • 92 citations
Sputum Cytopathology: Use and Potential in Monitoring the Workplace Environment by Screening for Biological Effects of Exposure
1986 • 90 citations
The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial
1992 • 86 citations
Protein Kinase C Targeting in Antineoplastic Treatment Strategies
1999 • 85 citations
Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.
2003 • 84 citations
Total cyclooxygenase‐2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non‐small cell lung cancer patients
2005 • 76 citations
Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice
2002 • 75 citations
Rapid Insulin-Like Growth Factor (IGF)-Independent Effects of IGF Binding Protein-3 on Endothelial Cell Survival
2003 • 74 citations
SMOKING AND LUNG CANCER
1959 • 72 citations
Chemoprevention of lung cancer—from biology to clinical reality
2004 • 51 citations
Celecoxib Decreases Ki-67 Proliferative Index in Active Smokers
2006 • 50 citations
Modulation of Pulmonary Leukotriene B4 Production by Cyclooxygenase-2 Inhibitors and Lipopolysaccharide
2004 • 49 citations
Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
2000 • 48 citations
Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy
2004 • 44 citations
Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
2003 • 43 citations
Localized Deficiencies of Folic Acid in Aerodigestive Tissues
1992 • 40 citations
Inhibition of Protein Kinase C—Do We, Can We, and Should We?
1999 • 39 citations
Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment.
1982 • 39 citations
Chemoprevention of benzo(a)pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R115777.
2003 • 38 citations
Lung cancer chemoprevention
2000 • 34 citations
Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf
2003 • 33 citations
High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia
2005 • 30 citations
The Proliferation-Specific Human Ki-67 Protein Is a Constituent of Compact Chromatin
2000 • 30 citations
Mechanisms of chemoprotection by oltipraz
1992 • 30 citations
Phase I/pharmacodynamic study of N-acetylcysteine/oltipraz in smokers: early termination due to excessive toxicity.
2001 • 27 citations
Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation.
1996 • 25 citations
Influenza Epidemic Alert
1957 • 11 citations
Chemoprevention of lung cancer
2002 • 11 citations
Excessive cigarette smoking: Statement
1957 • 9 citations
Chemoprevention for lung cancer
1998 • 2 citations